跳至主要内容
临床试验/CTRI/2011/05/001765
CTRI/2011/05/001765已完成4 期

Comparison of antiproteinuric efficacy of angiotensin II receptor blockers losartan, olmesartan, telmisartan: A three arm prospective randomized controlled trial. - ARLOT trial

il0 个研究点目标入组 150 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients of either gender above 18yrs of age
  • Willing to give written informed consent
  • Proteinuria more than 1000mg/day confirmed on two consecutive 24 hr urine samples and with serum creatinine less than 2 mg/dl

排除标准

  • Pregnancy or planned childbearing during specified study period
  • Serum creatinine more than 2 mg/dl and/or potassium more than 4.8mg/dl
  • Preexisting severe hepatic dysfunction
  • Uncontrolled hypertension (>160/100 mmHg)
  • Uncontrolled diabetes (random blood sugar >300)
  • Hemodynamic instability (systolic BP <90mmHg, NYHA III-IV CCF or other condition as judged by physician)
  • Bilateral renal artery stenosis

研究者

发起方
il

相似试验